Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program

/PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:...

Related Keywords

United States ,American ,Laine Yonker ,Rivka Neufeld ,Joseph Green ,Elran Haber ,R Balfour Sartor ,Lavie Bio Ltd ,Pcrohn Colitis Congress ,Biomica Ltd ,University Of North Carolina ,American Crohn Colitis Foundation ,Evogene Ltd ,Nasdaq ,Edison Group ,Casterra Ag Ltd ,Agplenus Ltd ,Canonic Ltd ,American Gastroenterological Association ,Colitis Congress ,American Crohn ,Colitis Foundation ,North Carolina ,Chapel Hill ,Biomica Scientific Board ,Biomica Chief Executive Officer ,Bacterial Products ,Computational Predictive Biology ,Big Data ,Artificial Intelligence ,Public Relations ,